Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02446444 |
| Title | Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer |
| Acronym | ENZARAD |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | University of Sydney |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | SVN | NZL | IRL | GBR | ESP | BEL | AUT | AUS |